Topic: Humans

Journal: Gynecologic Oncology

Documents

A list of abstracts that contain a topic of "Humans" and a journal name of "Gynecologic Oncology".

• Primary Insular Carcinoid of the Ovary.

  PMID: 16298421

• Villoglandular Adenocarcinoma of the Cervix: Clarity is Needed on the Histological Definition for This Difficult Diagnosis.

  PMID: 16266744

• Human Acellular Dermal Matrix for Closure of a Contaminated Gynecologic Wound.

  PMID: 17048346

• Juvenile Granulosa Cell Tumor of the Ovary Associated with Tuberous Sclerosis.

  PMID: 16516278

• Uterine Leiomyosarcoma with Osteoclast Like Giant Cells and Long Standing Systemic Symptoms.

  PMID: 16643995

• Clear Cell Adenocarcinoma of the Vagina in a Patient with Vaginal Endometriosis.

  PMID: 16996119

• Retroperitoneal Liposarcoma Weighing over One Hundred Pounds with Review of the Literature.

  PMID: 17007913

• Pegylated Liposomal Doxorubicin (Lipo-dox) for Platinum-resistant or Refractory Epithelial Ovarian Carcinoma: a Taiwanese Gynecologic Oncology Group Study with Long-term Follow-up.

  PMID: 16325239

• Identification of Prognostic Factors After Positive Second-look Surgery in Epithelial Ovarian Carcinoma.

  PMID: 16427689

• Breast Cancer Followed by Corpus Cancer: is There a Higher Risk for Aggressive Histologic Subtypes?

  PMID: 16483640

• Characterization of Human Leukocyte Antigen-g (Hla-g) Expression in Endometrial Adenocarcinoma.

  PMID: 16530254

• Endometrial Carcinoma First Presenting As Paraneoplastic Cerebellar Degeneration.

  PMID: 17428523

• Advanced Vulvar Carcinoma: is It Worth Operating? A Perioperative Management Protocol for Radical and Reconstructive Surgery.

  PMID: 16647747

• A Polymorphism in the Matrix Metalloproteinase-1 Gene Promoter is Associated with the Prognosis of Patients with Ovarian Cancer.

  PMID: 16214204

• Mesorectal Lymph Node Involvement and Prognostic Implications at Total Pelvic Exenteration for Gynecologic Malignancies.

  PMID: 16226800

• Significance of Early Changes in the Serum Ca-125 Antigen Level on Overall Survival in Advanced Ovarian Cancer.

  PMID: 16595148

• Testing of Two Binary Grading Systems for Figo Stage Iii Serous Carcinoma of the Ovary and Peritoneum.

  PMID: 16828848

• A Case of Monophasic Synovial Sarcoma Presenting As a Vulvar Mass.

  PMID: 16226798

• Full-thickness Diaphragmatic Resection for Stage Iv Ovarian Carcinoma Using the Endogia Stapling Device Followed by Diaphragmatic Reconstruction Using a Gore-tex Graft: a Case Report and Review of the Literature.

  PMID: 16226799

• A Case of a Pt3, Hpv 52-positive Vulvar Carcinoma in an 18-year-old Woman.

  PMID: 16473399

• Aggressive Carcinosarcoma of the Uterine Cervix Associated with High Levels of Granulocyte Colony Stimulating Factor: Case Report and Laboratory Correlates.

  PMID: 16782175

• Spontaneous Pregnancy Following Cytoreduction with Peritonectomy and Hyperthermic Intraperitoneal Chemotherapy.

  PMID: 16194563

• Significant Differences of Lymphocytes Isolated from Ascites of Patients with Ovarian Cancer Compared to Blood and Tumor Lymphocytes. Association of Cd3+cd56+ Cells with Platinum Resistance.

  PMID: 17433425

• Cyp1a1 Gene Polymorphism As a Risk Factor for Cervical Intraepithelial Neoplasia and Invasive Cervical Cancer.

  PMID: 16403567

• Lactate Dehydrogenase 5 (Ldh-5) Expression in Endometrial Cancer Relates to the Activated Vegf/Vegfr2(Kdr) Pathway and Prognosis.

  PMID: 16837029

• Postoperative Ileus After Para-aortic Lymphadenectomy: a Prospective Study.

  PMID: 16919717

• Long-term Survival of 106 Stage Iii Ovarian Cancer Patients with Minimal Residual Disease After Second-look Laparotomy and Consolidation Radiotherapy.

  PMID: 16987544

• Sexual Health in Women Treated for Cervical Cancer: Characteristics and Correlates.

  PMID: 17005248

• Prognostic Factors for Outcomes and Complications for Primary Squamous Cell Carcinoma of the Vagina Treated with Radiation.

  PMID: 17363046

• Intraperitoneal Chemotherapy for Patients with Advanced Ovarian Cancer: a Review of the Evidence and Standards for the Delivery of Care.

  PMID: 17368522

• Relationship of Estrogen and Progesterone Receptors to Clinical Outcome in Metastatic Endometrial Carcinoma: a Gynecologic Oncology Group Study.

  PMID: 17532033

• Final Results of a Phase 2 Study Using Continuous 5% Imiquimod Cream Application in the Primary Treatment of High-grade Vulva Intraepithelial Neoplasia.

  PMID: 17582474

• Phase Ii Study of Pegylated Liposomal Doxorubicin and Oxaliplatin in Relapsed Advanced Ovarian Cancer.

  PMID: 16239023

• Secondary Cytoreduction in the Management of Recurrent Uterine Leiomyosarcoma.

  PMID: 17434579

• Hpv16/18 E7-pulsed Dendritic Cell Vaccination in Cervical Cancer Patients with Recurrent Disease Refractory to Standard Treatment Modalities.

  PMID: 16249018

• A Case of C-kit Positive High-grade Stromal Endometrial Sarcoma Responding to Imatinib Mesylate.

  PMID: 16487996

• A Phase I Trial of Gemcitabine and Topotecan in Previously Treated Ovarian or Peritoneal Cancer: a Gynecologic Oncology Group Study.

  PMID: 16150481

• A Phase Ii Study of Irofulven in Women with Recurrent and Heavily Pretreated Ovarian Cancer.

  PMID: 16260029

• Paclitaxel and Carboplatin in the Adjuvant Treatment of Patients with High-risk Stage Iii and Iv Endometrial Cancer: a Retrospective Study.

  PMID: 16677690

• Polymorphism of Il-1alpha, Il-1beta and Il-10 in Patients with Advanced Ovarian Cancer: Results of a Prospective Study with 147 Patients.

  PMID: 17141301

• Safety and Efficacy of Lenalidomide (Revlimid) in Recurrent Ovarian and Primary Peritoneal Carcinoma.

  PMID: 17257661

• Treatment of Ovarian Cancer with a Novel Dual Targeted Conditionally Replicative Adenovirus (Crad).

  PMID: 17173958

• Hpv-induced Carcinogenesis of the Uterine Cervix is Associated with Reduced Serum Atra Level.

  PMID: 16554086

• Hpv Status in Sentinel Nodes Might Be a Prognostic Factor in Cervical Cancer.

  PMID: 17275890

• Comparison of Secondary and Primary Ovarian Malignancies Reveals Differences in Their Pre- and Perioperative Characteristics.

  PMID: 16278010

• Preoperative Serum Ykl-40 is a Marker for Detection and Prognosis of Endometrial Cancer.

  PMID: 17023034

• Endocervical Glandular Involvement is Associated with High-grade Sil.

  PMID: 16472847

• Gestational Trophoblastic Diseases: 3. Human Chorionic Gonadotropin-free Beta-subunit, a Reliable Marker of Placental Site Trophoblastic Tumors.

  PMID: 16631918

• Treatment of Squamous Cell Vulvar Cancer with the Anti-egfr Tyrosine Kinase Inhibitor Tarceva.

  PMID: 17561233

• Human Papillomavirus-type Persistence Patterns Predict the Clinical Outcome of Cervical Intraepithelial Neoplasia.

  PMID: 16483642

• Sequence Dependence of Hematologic Toxicity Using Carboplatin and Topotecan for Primary Therapy of Advanced Epithelial Ovarian Cancer: a Phase I Study of the Gynecologic Oncology Group.

  PMID: 16631245

• Promoter-specific Transcription of Insulin-like Growth Factor-ii in Epithelial Ovarian Cancer.

  PMID: 16859738

• The Risk of Persistent Trophoblastic Disease After Hydatidiform Mole Classified by Morphology and Ploidy.

  PMID: 17011616

• The Impact of Age in the Outcome of Patients with Advanced or Recurrent Cervical Cancer After Platinum-based Chemotherapy.

  PMID: 17030353

• Vegf- and Lpa-induced Telomerase in Human Ovarian Cancer Cells is Sp1-dependent.

  PMID: 17559911

• Gestational Trophoblastic Diseases: 4. Presentation with Persistent Low Positive Human Chorionic Gonadotropin Test Results.

  PMID: 16631243

• Efficacy of Systematic Lymphadenectomy and Adjuvant Radiotherapy in Node-positive Endometrial Cancer Patients.

  PMID: 16510174

• Total Laparoscopic Radical Hysterectomy and Lymphadenectomy: the M. D. Anderson Cancer Center Experience.

  PMID: 16472844

• Adjuvant Whole Abdominal Irradiation in Clinical Stages I and Ii Papillary Serous or Clear Cell Carcinoma of the Endometrium: a Phase Ii Study of the Gynecologic Oncology Group.

  PMID: 16213007

• Effectiveness of Postoperative Chemotherapy for Para-aortic Lymph Node Metastasis of Endometrial Cancer.

  PMID: 16457876

• A Critical Review of Patient-rated Quality of Life Studies of Long-term Survivors of Cervical Cancer.

  PMID: 16716379

• Claudin 1 Differentiates Endometrioid and Serous Papillary Endometrial Adenocarcinoma.

  PMID: 16797678

• Safety and Efficacy of Thalidomide in Recurrent Epithelial Ovarian and Peritoneal Carcinoma.

  PMID: 16828852

• Correlation Between Survivin Expression and Locoregional Control in Cervical Squamous Cell Carcinomas Treated with Radiation Therapy.

  PMID: 17141299

• Intraperitoneal Hyperthermic Chemotherapy Using Carboplatin: a Phase I Analysis in Ovarian Carcinoma.

  PMID: 17498782

• Urinary Mesothelin Provides Greater Sensitivity for Early Stage Ovarian Cancer Than Serum Mesothelin, Urinary Hcg Free Beta Subunit and Urinary Hcg Beta Core Fragment.

  PMID: 17532030

• The Safety and Efficacy of the Weekly Dosing of Irinotecan for Platinum- and Taxanes-resistant Epithelial Ovarian Cancer.

  PMID: 16298422

• Extracellular Matrix-induced Changes in Expression of Cell Cycle-related Proteins and Proteasome Components in Endometrial Adenocarcinoma Cells.

  PMID: 16497364

• Colposcopic Accuracy of Obstetrics and Gynecology Residents.

  PMID: 16875717

• Histone Deacetylase Inhibitors Induce Apoptosis in Both Type I and Type Ii Endometrial Cancer Cells.

  PMID: 17303224

• A Phase Ii Trial of Thalidomide in Patients with Refractory Leiomyosarcoma of the Uterus and Correlation with Biomarkers of Angiogenesis: a Gynecologic Oncology Group Study.

  PMID: 17597196

• Clinical Results and Quality of Life Analysis for the Mvac Combination (Methotrexate, Vinblastine, Doxorubicin, and Cisplatin) in Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group Study.

  PMID: 16216315

• Usefulness of Combining Testing for P16 Protein and Human Papillomavirus (Hpv) in Cervical Carcinoma Screening.

  PMID: 16494930

• Cytotoxic Effects of T Cells Induced by Fusion Protein 6b11-pulsed Dendritic Cells on Ovarian Carcinoma Cells.

  PMID: 17383546

• Which Clinical/Pathologic Factors Matter in the Era of Chemoradiation As Treatment for Locally Advanced Cervical Carcinoma? Analysis of Two Gynecologic Oncology Group (Gog) Trials.

  PMID: 17275889

• Is Egfr a Moving Target During Radiotherapy of Carcinoma of the Uterine Cervix?

  PMID: 17521713

• Bcl-x(L) is Functionally Non-equivalent for the Regulation of Growth and Survival in Human Ovarian Cancer Cells.

  PMID: 16188300

• A Comparison of Laparoscopic Radical Hysterectomy and Pelvic Lymphadenectomy and Laparotomy in the Treatment of Ib-iia Cervical Cancer.

  PMID: 17197013

---